Celldex Therapeutics reported $2.34M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
AbbVie USD 67.5B 67.5B Dec/2025
Agenus USD 35.54M 2.34M Mar/2025
Amgen USD 54.6B 17M Dec/2025
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Celldex Therapeutics USD 2.34M 285K Dec/2025
Glaxosmithkline GBP 17.75B 396M Sep/2025
Nektar Therapeutics USD 0 0 Jun/2022
Northwest Biotherapeutics USD 32.94M 6.93M Sep/2023
Pfizer USD 63.73B 231M Mar/2026
Rigel Pharmaceuticals USD 59.69M 90K Jun/2024
Roche Holding CHF 33.03B 1.41B Jun/2025